Rick E. Winningham - 20 Nov 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
20 Nov 2024
Transactions value $
-$159,490
Form type
4
Filing time
22 Nov 2024, 18:10:49 UTC
Previous filing
19 Nov 2024
Next filing
24 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$159K -16K -0.88% $9.97 1.81M 20 Nov 2024 Direct F1
holding TBPH Ordinary Shares 3.9K 20 Nov 2024 As Custodian
holding TBPH Ordinary Shares 92.6K 20 Nov 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.